+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Digital Pathology Market - Forecast (2022 - 2027)

  • PDF Icon


  • 131 Pages
  • February 2022
  • Region: Global
  • IndustryARC
  • ID: 5616346
The Digital Pathology Market size was estimated at $685.43 billion in 2020, growing at a CAGR of 8.2% during the forecast period 2022-2027. Digital pathology encompasses the collecting, management, exchange, and interpretation of pathology data, including slides and data, in a digital setting. Scanning is used to capture digital pathology images, and robotic microscopy can be used to get whole slide imaging / virtual microscopy on an entire histological (microscopic) glass slide. When glass slides are scanned with a scanning instrument, a high-resolution digital image is produced that may be viewed on a computer screen or mobile device. The increasing adoption of digital pathology to improve lab efficiency, the rising prevalence of cancer, and the growing application of digital pathology in drug development and companion diagnostics, as well as the reduction of high costs associated with conventional diagnostics, are all contributing to the market's growth. However, in the approaching years, a scarcity of qualified pathologists is projected to stifle market expansion for the period 2022-2027.

Report Coverage

The report: “Digital Pathology Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Digital Pathology Market.
  • By Product: Scanner, Software, Communication Systems, and Storage system.
  • By Type: Human Pathology and Veterinary Pathology.
  • By Application: Drug Discovery, Disease Diagnosis, Teleconsultation, and Training & Education.
  • By End User: Pharmaceutical & Biotechnology Companies, Hospitals, and Reference Laboratories, and Academic & Research Institutes.
  • By Geography: North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (the Middle East, and Africa).

Key Takeaways

The North America region dominated the Digital Pathology Market in 2020 and it is estimated to account for 38% of the total market share.

Technological advancement in Digital Pathology along with the growing application of digital pathology in drug development and companion diagnostics is set to aid the market growth.

The study conducted will give a detailed analysis of the main players functioning in the Digital Pathology Market's Strengths, Weaknesses, and Opportunities.

Digital Pathology Market Segment Analysis - By Application

Based on the Application, the market for Digital Pathology is categorized as Drug Discovery, Disease Diagnosis, Tele-consultation, and Training & Education. In 2020, the Drug Discovery segment dominated the digital pathology market, accounting for the greatest revenue share. This expansion is owing to the expansion in R&D expenditure, spurred by the requirement for numerous preclinical and clinical studies undertaken during the drug discovery and development process.

However owing to the rising prevalence of chronic diseases, the disease diagnosis sector is predicted to grow at the quickest rate of 9.8% throughout the projection period. Furthermore, manufacturers focus on the development of unique and speedy diagnostic techniques. Digital technologies make it easier to transfer information between departments and improve each step of the diagnostic process.

Digital Pathology Market Segment Analysis - By End User

Based on the End User, the market for Digital Pathology is categorized into Pharmaceutical & Biotechnology Companies, Hospitals and Reference Laboratories, and Academic & Research Institutes. In 2020, the pharmaceutical and biotechnology firms sector led the worldwide digital pathology market with the biggest share. The growing use of digital pathology for drug discovery research and drug toxicology testing can be linked to this segment's size. However, the hospitals and Reference Laboratories segment is anticipated to develop at the quickest CAGR of 10.4% in 2020, owing to the growing adoption of those strategies. Hospitals are adopting virtual scanning strategies for quicker analysis and higher affected person compliance.

Digital Pathology Market Segment Analysis - By Geography

North America dominated the digital pathology marketplace and held the biggest sales proportion of over 38% in 2020. Continual deployment of R&D investments, supportive authorities projects referring to the improvement of technologically superior systems, growing adoption of virtual imaging, and the presence of principal companies are the top factors contributing to this dominance. Increased use of digital pathology for disease detection, combined with advantageous reimbursement rules in the United States, is predicted to stimulate regional expansion by enhancing the quality of cancer diagnosis.

However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2022-2027 owing to the rising prevalence of cancer, which affects a huge population. Demand is also expected to be fueled by a growing desire for novel treatment options, enhanced patient care facilities, and decreasing laboratory prices.

Digital Pathology Market Drivers

Improve lab efficiency and rising cases of COVID are increasing the adoption of digital pathology techniques

  • By lowering costs, shortening turnaround times, and providing users with subject-matter expertise, digital pathology aids lab efficiency. Patients and clinicians rely on lab data for diagnostic decisions, therefore improvements in lab efficiency are crucial. Additionally, the web-based access to digitized slides minimizes shipping expenses and pathologists' travel time as a result diagnostic tests are conducted and reported swiftly and accurately.

Lockdowns and social distance restrictions have been implemented as a result of the COVID-19 epidemic. As a result of these constraints, demand for digital pathology technologies has increased, which allows pathologists to assess diagnostic results remotely for primary diagnosis. A considerable number of pathologists and pathology labs are using digital pathology in order to obtain a competitive advantage and provide speedy services

Digital Pathology Market Challenges

High Cost of the technique coupled with the scarcity of qualified individuals in pathology technique

Despite the fact that large hospitals with large capital budgets may purchase these technologies, pathologists and academic institutes with limited funds or IT assistance sometimes cannot afford as the cost of systems ranges from $1,00,000 to $5,00,000. It is highly expensive to implement because it comprises a number of linked technologies such as scanners, computers, pathologists' workstations, and medical displays. Additionally, pathologists are vital in completing laboratory tests however, there is currently a mismatch between supply and demand for pathologists around the world, particularly in the Asia Pacific and Africa. As a result the higher expense of these systems, along with a scarcity of qualified individuals to operate digital pathology equipment, is predicted to limit their use.

Digital Pathology Market Landscape

Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Digital Pathology Market. In 2020, the Digital Pathology Market share was consolidated by the top ten players present in the market. The Digital Pathology Market, the top 10 companies include:

  • Danaher
  • Hamamatsu Photonics, Inc.
  • Koninklijke Philips N.V.
  • Olympus Corporation
  • F. Hoffmann-La Roche Ltd.
  • Mikroscan Technologies
  • Inspirata, Inc.
  • Visiopharm A/S
  • Huron Digital Pathology
  • 3DHISTECH Ltd.


In August 2020, Danaher debuted Aperio GT 450 DX in Europe, and this device was launched in the Asia Pacific in May. Scanner Aperio GT 450 DX combines exceptional image quality and speedy scanning by combining proprietary real-time focusing with custom-designed Leica objectives. This ground-breaking technology enables laboratories to scale up digital pathology for routine diagnoses at high throughput.

In January 2020, Roche has released its cutting-edge uPath enterprise software for digital pathology. The uPath enterprise software builds on the previous version, known as VENTANA Virtuoso, by offering a new standard of customisation for pathological workflows. The uPath software improves the user experience by substantially reducing image rendering times, including automated image analysis, and increasing efficiency by allowing pathologists to share cases more easily.

This product will be delivered within 2 business days.

Table of Contents

1. Digital Pathology Market - Overview
1.1 Definitions and Scope
2. Digital Pathology Market - Executive Summary
2.1 Market Revenue and Key Trends
2.2 Key trends by Product
2.3 Key trends by Type
2.4 Key trends by Geography
3. Digital Pathology Market - Comparative Analysis
3.1 Product Benchmarking - Key Companies
3.2 Financial Analysis - Key Companies
3.3 Market Value Split by Key Companies
3.4 Patent Analysis
3.5 Pricing Analysis- Average Selling Price
4. Digital Pathology Market Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters five force model
4.3.1 Bargaining power of suppliers
4.3.2 Bargaining powers of customers
4.3.3 Threat of new entrants
4.3.4 Rivalry among existing players
4.3.5 Threat of substitutes
5. Digital Pathology Market - Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. Digital Pathology Market - By Product(Market Size -$Million/$Billion)
6.1 Scanners
6.2 Software
6.3 Communication Systems
6.4 Storage Systems
7. Digital Pathology Market - By Type (Market Size -$Million/$Billion)
7.1 Human Pathology
7.2 Veterinary Pathology
8. Digital Pathology Market - By Application (Market Size -$Million/$Billion)
8.1 Drug Discovery
8.2 Disease Diagnosis
8.3 Teleconsultation
8.4 Training & Education
9. Digital Pathology Market - By End User(Market Size -$Million/$Billion)
9.1 Pharmaceutical & Biotechnology Companies
9.2 Hospitals and Reference Laboratories
9.3 Academic & Research Institutes
10. Digital Pathology Market - By Geography(Market Size -$Million/$Billion)
10.1 North America
10.1.1 U.S.
10.1.2 Mexico
10.1.3 Canada
10.2 Europe
10.2.1 U.K.
10.2.2 France
10.2.3 Germany
10.2.4 Italy
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Asia Pacific
10.3.1 China
10.3.2 India
10.3.3 Japan
10.3.4 South Korea
10.3.5 Australia & New Zealand
10.3.6 Rest of APAC
10.4 South America
10.4.1 Brazil
10.4.2 Argentina
10.4.3 Others
10.5 Rest of the World
10.5.1 Middle East
10.5.2 Africa
11. Digital Pathology Market - Entropy
12. Digital Pathology Market Company Analysis (Company Revenue, Product, M&A, Developments)
12.1 Company 1
12.2 Company 2
12.3 Company 3
12.4 Company 4
12.5 Company 5
12.6 Company 6
12.7 Company 7
12.8 Company 8
12.9 Company 9
12.10 Company 10